With Sales growing in India, Japan and South Africa and progress on three dfifferent molecules Lupin ended June 30 with $1.5 bln run rate for the year scoring Rs1.5 bln in Sales.
- A bad dip for Indian healthcare midcaps (awardz.wordpress.com)
- Lupin mulls sale of its Indian unit that markets drugs (donttradeourlivesaway.wordpress.com)
- Happy Thursdays! Inflation inches down, Europe cracks (awardz.wordpress.com)
- Medicis inks $58M dermatology pact with India’s Lupin (fiercebiotech.com)
- India Earnings Season: Dr Reddy’s redeems the sector’s performance (awardz.wordpress.com)